Reversal of convention: From man to experimental animal in elucidating the function of the renal amiloride-sensitive sodium channel

Experimental Nephrology

Volumn 6, Issue 4, 1998, Pages 265-271

  Hummler, Edith ^a,b  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

^b Inst de Pharmacologie   (Switzerland)

Author keywords

Aldosterone; Amiloride sensitive sodium channel Kidney; Hypertension models; Salt sensitivity; Sodium homeostasis

Indexed keywords

AMILORIDE; CELL MEMBRANE PROTEIN; SODIUM CHANNEL;

CELL MEMBRANE TRANSPORT; CHANNEL GATING; GENE MUTATION; GENE REPRESSION; HUMAN; HYPERTENSION; LIDDLE SYNDROME; NONHUMAN; PRIORITY JOURNAL; SHORT SURVEY; SODIUM BALANCE; STRUCTURE ACTIVITY RELATION;

EID: 0031849683     PISSN: 10187782     EISSN: None     Source Type: Journal    
DOI: 10.1159/000020531     Document Type: Short Survey

References (56)

1. Guyton AC: Blood pressure control: Special role of the kidneys and body fluids. Science 1991;252: 1813-1816.
2. Lifton RP: Genetic determinants of human hypertension. Proc Natl Acad Sci USA 1995;92: 8545-8551.
3. Canessa CM, Horisberger JD, Rossier BC: Epithelial sodium channel related to proteins involved in neurodegeneration. Nature 1993;361: 467-470.
4. + channel is made of three homologous subunits. Nature 1994;367:463- 467.
5. May A, Puoti A, Gäggeler H-P, Horisberger J-D, Rossier BC: Early effect of aldosterone on the rate of synthesis of the epithelial sodium channel a subunit in A6 renal cells. JASN 1997; in press.
6. Ausiello DA, Skorecki KL, Verkman AS, Bonventre JV: Vasopressin signaling in kidney cells. Kid Int 1987; 31: 521-529.
7. Knepper MA, Lankford SP, Terada Y: Renal tubular actions of ANF. Can J Physiol Pharmacol 1991;69: 1537-1545.
8. Rossier BC, Canessa CM, Schild L, Horisberger J-D: Epithelial sodium channels. Curr Opin Nephrol Hypertens 1994;3: 387-496.
9. Driscoll M, Chalfie M: Developmental and abnormal cell death in C. elegans. Trends Neurosci 1992;15: 15-19.
10. Lingueglia E, Champigny G, Lazdunski M, Barbry P: Cloning of the amiloride-sensitive FMRFamide peptide-gated sodium channel. Nature 1995;378: 730-733.
11. + channel. J Biol Chem 1996;271: 7879-7882.
12. Garcia-Anoveros J, Derfler B, Neville-Golden J, Hyman BT, Corey DP: BNaC1 and BNaC2 constitute a new family of human neuronal sodium channels related to degenerins and epithelial sodium channels. Proc Natl Acad Sci USA 1997;94: 1449-1464.
13. Waldmann R, Champigny G, Bassilana F, Heurteaux C, Lazdunski M: A proton-gated cation channel involved in acid sensing. Nature 1997;386: 173-177.
14. + channels. FASEB J 1994;8:522- 528.
15. Liddle GW, Bledsoe T, Coppage WS: A familial renal disorder simulating primary aldosteronism but with negligible aldosterone secretion. Trans Assoc Phys 1963;76: 199-213.
16. Horisberger J-D, Puoti A, Canessa C, Rossier BC: The amiloride receptor. J Clin Invest 1994;72: 695-697.
17. Shimkets RA, Warnock DG, Bositis CM, Nelson-Williams C, Hansson JH, Schambelan M, Gill JR Jr, Ulick S, Milora RV, Findling JW, Canessa CM, Rossier BC, Lifton RP: Liddle's syndrome: Heritable human hypertension caused by mutations in the β subunit of the epithelial sodium channel. Cell 1994;79: 407-414.
18. Schild L, Lu Y, Gaulschi I, Schneeberger E, Lifton RP, Rossier BC: Identification of a PY motif in the epithelial Na channel subunits as a target sequence for mutations causing channel activation found in Liddle syndrome. EMBO J 1996;15: 2381-2387.
19. + channel. Cell 1995;83:969- 978.
20. Schild L, Canessa CM, Shimkets RA, Warnock DG, Lifton RP, Rossier BC: A mutation in the epithelial sodium channel causing Liddle's disease increases channel activity in the Xenopus laevis oocyte expression system. Proc Natl Acad Sci USA 1995;92: 5699-5703.
21. Firsov D, Schild L, Gautschi I, Mérillat A-M, Schneeberger E, Rossier BC: Cell surface expression of the epithelial Na channel and a mutant causing Liddle syndrome: A quantitative approach. Proc Natl Acad Sci USA 1996;93: 15370-15375.
22. + cannel deleted in Liddle's syndrome. EMBO J 1996;15: 2371-2380.
23. Sudol M, Chen HI, Bougeret C, Einbond A, Bork P: Characterization of a novel protein-binding module - The WW domain. FEBS Lett 1995;369: 67-71.
24. Chang SS, Gründer S, Hanukoglu A, Rösler A, Mathew PM, Hanukoglu I, Schild L, Lu Y, Shimkets RA, Nelson-Williams C, Rossier BC, Lifton RP: Mutations in subunits of the epithelial sodium channel cause salt wasting with hyperkalaemic acidosis, pseudohypoaldosteronism type 1. Nature Genet 1996;12: 248-253.
25. Strautnieks SS, Thompson RJ, Hanukoglu A, Dillon MJ, Hanukoglu I, Kuhnle U, Seckl J, Gardiner RM, Chu ng E: Localisation of pseudohypoaldosteronism genes to chromosome 16p12.2-13.11 and 12p13.1-pter by homozygosity mapping. Hum Mol Genet 1996;5: 293-299.
26. Gründer S, Firsov D, Chang SS, Fowler-Jaeger N, Gautschi I, Schild L, Lifton RL, Rossier BC: A mutation causing pseudohypoaldosteronism type 1 identifies a conserved glycine that is involved in the gating of the epithelial sodium channel. EMBO J 1997;16: 899-907.
27. Strautnieks SS, Thompson RJ, Gardiner RM, Chung E: A novel splice-site mutation in the gamma subunit of the epithelial sodium channel gene in three pseudohypoaldosteronism type 1 families. Nature Genet 1996;13: 248-250.
28. Clark AF, Scharp MG, Mullins JJ: Gene targeting and its application to basic hypertension research. Clin Sci 1996;90: 435-446.
29. Gründer S, Zagato L, Yagil C, Yagil Y, Sassard J, Rossier BC: Polymorphisms in the carboxy-terminus of the epithelial sodium channel in rat models for hypertension. J Hypertens 1997;93: 173-179.
30. Voilley N, Bassilana F, Mignon C, Merscher S, Mattéi M-G, Carle GF, Lazdunski M, Barbry P: Cloning, chromosomal localization, and physical linkage of the β and γ subunits (SCNN1B and SCNN1G) of the human epithelial amiloride-sensitive sodium channel. Genomics 1995;28: 560-565.
31. Lindpaintner K, Hilbert P, Ganten D, Nadal GB, Inagami T, Iwai N: Molecular genetics of the SA-gene: Cosegregation with hypertension and mapping to rat chromosome I. J Hypertens 1993;11: 19-23.
32. Inoue J, Nakajima T, Williams CS, Quackenbush I, Puryear R, Powers M, Cheng T, Ludwig EH, Sharma AM, Hata A, Jeunemaître X, Lalouel J-M: A nucleotide substitution in the promoter of human angiotensinogen is associated with essential hypertension and affects basal transcription in vitro. J Clin Invest 1997;99: 1786-1797.
33. Smithies O, Maeda N: Gene targeting approaches to complex genetic diseases: Atherosclerosis and essential hypertension. Proc Natl Acad Sci USA 1995;92: 5266-5272.
34. Tanimoto K, Sugiyama F, Goto Y, Ishida J, Takimoto E, Yagami K, Fukamizu A, Murakami K: Angiotensinogen-deficient mice with hypotension. J Biol Chem 1994;269: 31334-31337.
35. Krege JH, John SWM, Langenbach LL, Hodgin JB, Hagaman JR, Bachman ES, Jennette JC, O'Brien DA, Smithies O: Male-female differences in fertility and blood pressure in ACE-deficient mice. Nature 1995;375: 146-148.
36. Ito M, Oliverio MI, Mannon PJ, Best CF, Maeda N, Smithies O, Coffman TM: Regulation of blood pressure by the type 1A angiotensin II receptor gene. Proc Natl Acad Sci USA 1995;92: 3521-3525.
37. Sugaya T, Nishimatsu S, Tanimoto K, Takimoto E, Yamagishi T, Imamura K, Goto S, Imaizumi K, Hisada Y, Otsuka A, et al: Angiotensin II type 1a receptor-deficient mice with hypotension and hyperreninemia. J Biol Chem 1995;270: 18719-18722.
38. Kim HS, Krege JH, Kluckman KD, Hagaman JR, Hodgin JE, Best CF, Jennette JC, Coffman TM, Maeda N, Smithies O: Genetic control of blood pressure and the angiotensinogen locus. Proc Natl Acad Sci USA 1995;92: 2735-2739.
39. Ichiki T, Labosky PA, Shiota C, Okuyama S, Imagawa Y, Fogo A, Niimura F, Ichikawa I, Hogan BL, Inagami T: Effects on blood pressure and exploratory behaviour of mice lacking angiotensin II type-2 receptor. Nature 1995;377.748-750.
40. Hein L, Barsh GS, Pratt RE, Dzau VJ, Kobilka BK: Behavioural and cardiovascular effects of disrupting the angiotensin II type-2 receptor in mice. Nature 1995;377: 744-747.
41. Hummler E, Barker P, Gatzy J, Beermann F, Verdumo C, Schmidt A, Boucher R, Rossier BC: Early death due to defective neonatal lung liquid clearance in αENaC-deficient mice. Nature Genet 1996;12: 325-328.
42. + channel in the developing rat lung. Am J Physiol 1993;265: 0491-496.
43. + channel: Biophysical properties, pharmacology, ontogenesis, and molecular cloning. Proc Natl Acad Sci USA 1994;91:247- 251.
44. Barker PM, Gatzy JT: Effects of gas tension on liquid flow across explants from distal fetal rat lung. Am J Physiol 1993;265:L 512-L517.
45. Cole TJ, Blendy JA, Monaghan AP, Krieglstein K, Schmid W, Aguzzi A, Fantuzzi G, Hummler E, Unsicker K, Schütz G: Targeted disruption of the glucocorticoid receptor gene blocks adrenergic chromaffin cell development and severely retards lung maturation. Genes Dev 1995;9: 1608-1621.
46. + channel by steroid hormones. EMBO J 1994;13: 2177-2181.
47. Barker PM, Gowen CW, Lawson EE, Knowles MR: Decreased sodium ion absorption across nasal epithelium of very premature infants with respiratory distress syndrome. J Pediatr 1997;130: 373-377.
48. Hanukoglu A, Bistritzer T, Rakover Y, Mandelberg A: Pseudohypoaldosteronism with increased sweat and saliva electrolyte values and frequent lower respiratory tract infections mimicking cystic fibrosis. J Pediatr 1994;125: 752-755.
49. Hummler E, Barker P, Talbot C, Wang Q, Verdumo C, Grubb B, Gatzy J, Burnier M, Horisberger J-D, Beermann F, Boucher R, Rossier BC: A mouse model for the renal salt-wasting syndrome pseudohypoaldosteronism. Proc Natl Acad Sci USA 1997;94: 11710-11715.
50. Su YR, Rutkowski MP, Klanke CA, Wu XM, Cui Y, Pun R, Carter V, Reif M, Menon AG: A novel variant of the beta-subunit of the amiloride-sensitive sodium channel in African Americans. J Am Soc Nephrol 1996;7: 2543-2549.
51. Sauer B: Manipulation of transgenes by site-specific recombination: Use of Cre recombinase. Meth Enzymol 1993;225: 890-901.
52. Zou Y-R, Müller W, Gu H, Rajewski K: CreloxP-mediated gene replacement: A mouse strain producing humanized antibodies. Curr Biol 1994;12: 1099-1103.
53. Brown DM, Provoost AP, Daly MJ, Lander ES, Jacob HJ: Renal disease susceptibility and hypertension are under independent genetic control in the fawn-hooded rat. Nature Genet 1997;12: 44-51.
54. Hansson J, Schild L, Gautschi I, Lu Y, Wilson T, Shimkets R, Nelson-Williams C, Rossier BC, Lifton R: A de novo missense mutation altering a proline-rich segment of the β subunit of the epithelial sodium channel causes hypertension and Liddle's syndrome. Proc Natl Acad Sci USA 1995;92: 11495-11499.
55. Tamura H, Schild L, Enomoto N, Matsui N, Marumo F, Rossier BC, Sasaki S: Liddle disease caused by a missense mutation of β sub-unit of the epithelial sodium channel gene. J Clin Invest 1996;97: 1780-1784.
56. Hansson JH, Nelson-Williams C, Suzuki H, Schild L, Shimkets R, Lu Y, Canessa C, Iwasaki T, Rossier BC, Lifton RP: Hypertension caused by a truncated epithelial sodium channel γ subunit: Genetic heterogeneity of Liddle syndrome. Nature Genet 1995;11: 76-82.